Rethinking the diagnostic criteria of polycythemia vera (Q38172388)

30 August 2017

title

Rethinking the diagnostic criteria of polycythemia vera (English)

1 reference

30 August 2017

4

A Tefferi

1 reference

30 August 2017

T Barbui

1

1 reference

30 August 2017

J Thiele

series ordinal

2

1 reference

30 August 2017

A M Vannucchi

series ordinal

3

1 reference

30 August 2017

publication date

19 December 2013

1 reference

30 August 2017

1 reference

30 August 2017

volume

28

1 reference

30 August 2017

issue

6

1 reference

30 August 2017

page(s)

1191-1195

1 reference

Amendment to the guideline for diagnosis and investigation of polycythaemia/erythrocytosis.

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.380

Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.380

The myeloproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.380

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.380

A gain-of-function mutation of JAK2 in myeloproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.380

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.380

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.380

Prevalence and clinicopathologic correlates of JAK2 exon 12 mutations in JAK2V617F-negative polycythemia vera.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.380

JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.380

Polycythemia vera: myths, mechanisms, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.380

An elevated venous haemoglobin concentration cannot be used as a surrogate marker for absolute erythrocytosis: a study of patients with polycythaemia vera and apparent polycythaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.380

The revised World Health Organization diagnostic criteria for polycythemia vera, essential thrombocytosis, and primary myelofibrosis: an alternative proposal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.380

Red cell mass measurement in patients with clinically suspected diagnosis of polycythemia vera or essential thrombocythemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.380

Evaluation of WHO criteria for diagnosis of polycythemia vera: a prospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.380

Initial (latent) polycythemia vera with thrombocytosis mimicking essential thrombocythemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.380

The significance of bone marrow biopsy and JAK2V617F mutation in the differential diagnosis between the "early" prepolycythemic phase of polycythemia vera and essential thrombocythemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.380

Primary myelofibrosis (PMF), post polycythemia vera myelofibrosis (post-PV MF), post essential thrombocythemia myelofibrosis (post-ET MF), blast phase PMF (PMF-BP): Consensus on terminology by the international working group for myelofibrosis resear

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.380

Diagnosis and classification of erythrocytoses and thrombocytoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.380

The classification and diagnostic criteria of the erythrocytoses (polycythaemias)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.380

Guidelines for the diagnosis, investigation and management of polycythaemia/erythrocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.380

21 January 2018

Apparent polycythaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.380

Red cell mass and plasma volume measurements in polycythemia: evaluation of performance and practical utility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.380

Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.380

Classification and staging of Ph-negative myeloproliferative disorders by histopathology from bone marrow biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.380

The histopathology of chronic myeloproliferative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.380

The 2008 WHO diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.380

Initial bone marrow reticulin fibrosis in polycythemia vera exerts an impact on clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.380

Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.380

Diagnosing polycythemia vera: a paradigm shift

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.380

Cardiovascular events and intensity of treatment in polycythemia vera

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.380

Revised response criteria for polycythemia vera and essential thrombocythemia: an ELN and IWG-MRT consensus project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.380

Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.380

Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.380

Myelofibrosis in chronic myeloproliferative disorders. Incidence among subtypes according to the Hannover Classification

21 January 2018

1 reference

12 December 2020

Masked polycythemia vera (mPV): results of an international study

1 reference

12 December 2020

Masked polycythemia vera diagnosed according to WHO and BCSH classification.

1 reference

12 December 2020

A prospective study of the value of bone marrow erythroid progenitor cultures in polycythemia

1 reference

12 December 2020

Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols.

1 reference

12 December 2020

Standardization of bone marrow features--does it work in hematopathology for histological discrimination of different disease patterns?

1 reference

12 December 2020

The bone marrow in polycythemia vera

1 reference

12 December 2020

Diagnostic impact of bone marrow histopathology in polycythemia vera (PV).

1 reference

12 December 2020

The classification and diagnosis of erythrocytosis

1 reference

12 December 2020

The bone marrow in polycythemia vera

1 reference

12 December 2020

European consensus on grading bone marrow fibrosis and assessment of cellularity

1 reference

12 December 2020

Histologic findings in bone marrow biopsies of patients with thrombocythemic cell counts

1 reference

12 December 2020

Diagnosis and classification of the polycythemias

1 reference

12 December 2020

Prodromal myeloproliferative neoplasms: the 2008 WHO classification

1 reference

12 December 2020

Comparison of erythroid progenitor cell growth in vitro in polycythemia vera and chronic myelogenous leukemia: only polycythemia vera has endogenous colonies

1 reference

12 December 2020

Studies of the bone marrow in polycythemia vera and the evolution of myelofibrosis and second hematologic malignancies

1 reference

12 December 2020

Polycythemia vera: the natural history of 1213 patients followed for 20 years. Gruppo Italiano Studio Policitemia

1 reference

12 December 2020

Diagnostic value of serum erythropoietin level in patients with absolute erythrocytosis

1 reference

12 December 2020

The value of bone marrow histology in differentiating between early stage Polycythemia vera and secondary (reactive) Polycythemias

1 reference

12 December 2020

The rise and fall of red cell mass measurement in polycythemia vera

1 reference

12 December 2020

Histomorphometry of bone marrow biopsies in chronic myeloproliferative disorders with associated thrombocytosis--features of significance for the diagnosis of primary (essential) thrombocythaemia

1 reference

12 December 2020

Polycythemia rubra vera versus secondary polycythemias. A clinicopathological evaluation of distinctive features in 199 patients

1 reference

12 December 2020

Evaluation of diagnostic criteria in polycythemia vera

1 reference

12 December 2020

Diagnostic criteria and prognosis in polycythemia vera and essential thrombocythemia

1 reference

12 December 2020

Megakaryocyte and erythroid colony formation in essential thrombocythaemia and reactive thrombocytosis: diagnostic value and correlation to complications

1 reference

12 December 2020

Identifiers

DOI

10.1038/LEU.2013.380

1 reference

Dimensions Publication ID

30 August 2017

1034544532

0 references

1 reference